View of Comparison of Metformin Versus Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus

Return to Article Details Comparison of Metformin Versus Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus Download Download PDF